Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)

Market Cap	4.58B +29.6%
Revenue (ttm)	1.47B -1.8%
Net Income	162.56M -6.7%
EPS	0.85 -6.1%
Shares Out	190.18M
PE Ratio	28.32
Forward PE	n/a
Dividend	0.50 (2.08%)
Ex-Dividend Date	Nov 28, 2025

Volume	2,315,500
Average Volume	1,466,108
Open	23.88
Previous Close	24.07
Day's Range	23.69 - 24.65
52-Week Range	17.62 - 41.47
Beta	0.11
RSI	46.53
Earnings Date	Apr 28, 2026

About SHE:003020

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethylphenidate HCL, dioctyl sulfosuccinate sodium salt, and DMSA. It also provides intermediate products, such as sodium paeonolsilate, methy2-(2,3-dichlor...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 1,456
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 003020

Financial Performance

In 2024, SHE:003020's revenue was 1.52 billion, a decrease of -20.11% compared to the previous year's 1.90 billion. Earnings were 160.60 million, a decrease of -29.15%.